BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6268719)

  • 21. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line.
    Drewinko B; Romsdahl MM; Yang LY; Ahearn MJ; Trujillo JM
    Cancer Res; 1976 Feb; 36(2 Pt 1):467-75. PubMed ID: 1260746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models.
    Kishikawa T; Sakamoto M; Ino Y; Kubushiro K; Nozawa S; Hirohashi S
    Invasion Metastasis; 1995; 15(1-2):11-21. PubMed ID: 7545653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
    Ruan HY; Li DR; Li L; Guan X; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma.
    Ishiwata I; Ishiwata C; Kobayashi N; Ishikawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):831-6. PubMed ID: 3598277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
    McCluggage WG; Young RH
    Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs].
    Yoshiya N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1747-53. PubMed ID: 3782955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of leukocyte migration in agar by soluble extract from a human ovarian carcinoma cell line.
    Sekiguchi M; Shibusawa M; Asanuma K; Kaku R; Wagatsuma T; Kobayashi H; Fujii G
    Jpn J Exp Med; 1982 Jun; 52(3):119-24. PubMed ID: 7131857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reorganization of human ovarian adenocarcinoma cells and endometrial adenocarcinoma cells cultured in double-layered floating collagen gels].
    Tsumura N; Kudo R; Sawada N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2157-70. PubMed ID: 3027213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Establishment and characterization of a cell line derived from human ovarian mucinous cystadenocarcinoma].
    Wan Q; Xu D; Li Z
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jul; 36(7):421-3. PubMed ID: 11718030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Establishment and characterization of human ovarian endometrioid carcinoma cell line].
    Uehara S; Soh K; Hoshiai H; Yajima A; Suzuki M; Abe H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):19-26. PubMed ID: 6827161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Establishment and biological characteristics of an immortalized human ovarian sarcomatoid carcinoma cell line BUPH:OVSC-2].
    Feng J; Liu GZ; Fu TY; Ye X; Yao Y
    Ai Zheng; 2002 Jul; 21(7):731-4. PubMed ID: 12479096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary.
    Yamada T; Ueda M; Otsuki Y; Ueki M; Sugimoto O
    Gynecol Oncol; 1991 Feb; 40(2):118-28. PubMed ID: 2010102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphologic characteristics, proliferation, and tumor marker expression of two human ovarian carcinoma cell lines in three-dimensional culture.
    Morimitsu Y; Yano H; Kojiro M
    Gynecol Oncol; 1993 Feb; 48(2):155-64. PubMed ID: 8428685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary.
    Wilson AP
    J Natl Cancer Inst; 1984 Mar; 72(3):513-21. PubMed ID: 6583437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and preliminary characterization of an ovarian carcinoma cell line from a patient with familial ovarian cancer.
    Buller RE; Niemann T; Connor JP; Squatrito RC; Skilling JS; Anderson B
    Gynecol Oncol; 1995 Jan; 56(1):39-44. PubMed ID: 7821846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer.
    Tagliabue E; Mènard S; Della Torre G; Barbanti P; Mariani-Costantini R; Porro G; Colnaghi MI
    Cancer Res; 1985 Jan; 45(1):379-85. PubMed ID: 3965146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new in vitro cell line established from human oat cell carcinoma of the lung.
    Ohara H; Okamoto T
    Cancer Res; 1977 Sep; 37(9):3088-95. PubMed ID: 195719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signet ring stomach cancer: morphological characterization and antigenic profile of a newly established cell line (Mz-Sto-1).
    Dippold WG; Kron G; Boosfeld E; Dienes HP; Klingel R; Knuth A; Wagner R; Meyer Zum Büschenfelde KH
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):697-706. PubMed ID: 2820743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.